Good morning :)
Medico Intercontinental Ltd

Medico Intercontinental Ltd

MIL Share Price

BSE
26.490.97% (-0.26)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹26 cr, stock is ranked 4,375

Stock is 4.29x as volatile as Nifty

MIL Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹26 cr, stock is ranked 4,375

Stock is 4.29x as volatile as Nifty

MIL Performance & Key Metrics

MIL Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-6.710.54
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
47.205.920.48%

MIL Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

MIL Company Profile

Medico Intercontinental Ltd is engaged in the trading of pharmaceutical products

PE Ratio
38.40
38.40
1Y Return
11.45%
11.45%
Buy Reco %
93.33
93.33
PE Ratio
85.10
85.10
1Y Return
35.67%
35.67%
Buy Reco %
81.48
81.48
PE Ratio
22.96
22.96
1Y Return
10.70%
10.70%
Buy Reco %
55.56
55.56
PE Ratio
29.04
29.04
1Y Return
11.64%
11.64%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
118.79
118.79
1Y Return
111.64%
111.64%
Buy Reco %
58.33
58.33
Compare with Peers

MIL Forecast

MIL Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

MIL

MIL

Income

Balance Sheet

Cash Flow

MIL Income Statement

MIL Income Statement

Loading...

Quartermar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue15.8419.3936.5518.5621.2721.6520.9520.1922.6020.85
Operating & Other expensessubtract14.1617.6533.7416.5319.2220.6821.2818.2620.8821.40
Depreciation/Amortizationsubtract0.080.080.200.230.280.621.951.431.431.21
Interest & Other Itemssubtract0.160.180.280.240.302.362.061.901.851.91
Taxes & Other Itemssubtract0.410.410.690.390.31-1.33-2.69-1.19-0.90-2.24
EPS1.041.081.631.171.17-0.68-1.65-0.22-0.65-1.45

MIL Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual report

PDF
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
 

MIL Stock Peers

MIL Past Performance & Peer Comparison

MIL Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Medico Intercontinental Ltd-8.250.54
Sun Pharmaceutical Industries Ltd38.405.260.87%
Torrent Pharmaceuticals Ltd85.1010.470.70%
Zydus Lifesciences Ltd22.963.910.09%

MIL Stock Price Comparison

Compare MIL with any stock or ETF
Compare MIL with any stock or ETF
MIL
Loading...

MIL Holdings

MIL Shareholdings

MIL Promoter Holdings Trend

MIL Promoter Holdings Trend

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 1.37%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

MIL Institutional Holdings Trend

MIL Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

MIL Shareholding Pattern

MIL Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding58.51%0.00%0.00%0.00%41.49%

Sep 2025

Dec 2025

Mar 2026

Jun 2026

MIL Shareholding History

MIL Shareholding History

MarJunSepDec '25MarJun0.00%0.00%0.00%0.00%0.00%0.00%

MIL Insider Trades & Bulk Stock Deals

MIL Insider Trades & Bulk Stock Deals

Loading...

smallcases containing MIL stock

smallcases containing MIL stock

Looks like this stock is not in any smallcase yet.

MIL Events

MIL Events

MIL Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

MIL Dividend Trend

No dividend trend available

MIL Upcoming Dividends

MIL Upcoming Dividends

No upcoming dividends are available

MIL Past Dividends

MIL Past Dividends

Cash Dividend

Ex DateEx DateJun 23, 2023

Final
Final | Div/Share: ₹0.10

Dividend/Share

0.10

Ex DateEx Date

Jun 23, 2023

MIL Stock News & Opinions

MIL Stock News & Opinions

Corporate
Corporate
Medico Intercontinental Limited schedules AGM on September 30, 2026, via video conference

Medico Intercontinental Limited informed the BSE Limited and CSE - India that its Board of Directors decided to convene the Annual General Meeting on Wednesday, 30th September 2026 at 02:00 P.M. through Video Conferencing (VC) / Other Audio Visual Means (OAVM), with the Register of Transfer and Register of Members to remain closed from September 24th, 2026 to September 30th, 2026, and a Record Date for E-Voting set for Wednesday, 23rd September 2026.

2 weeks agoCapital Market - Live
Earnings
Earnings
Medico Intercontinental Ltd consolidated sales down 7.91% on year in Q2FY2026, net profit soared by 73.19%

Medico Intercontinental Ltd share price softened by 1.27% to Rs 28.01 after the company's net profit jumped 73.19% to Rs 4.07 crore, while revenue from operations eased by 7.91% to Rs 20.71 crore in Q2FY26 over Q1FY26. The market capitalization of Trading & Distributors industry group stocks on BSE stood at Rs 49691.37 crore, falling 11.57%. It has slipped by 0.67% over last one week and jumped by 24.91% in last one month while the market capitalization of Medico Intercontinental Ltd has eased by 3.35% and 21.84% in the same period respectively. Profit before tax (PBT) of Medico Intercontinental Ltd stood at Rs 3.68 crore in Q2 FY26, surging by 83.08% year-on-year, and rallying 137.42% quarter-on-quarter. EBITDA came in at Rs 1 crore, nosediving by 300.00% YoY and plunging by 154.67% sequentially. Total expenses posted a minor rise of 1.39% to Rs 22.61 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 2.79 crore, advancing by 18.72% YoY, while employee benefits expense was at Rs 2.56 crore, soaring 13.78% YoY. For the TTM ended FY26, revenue from operations surged 33.58% to Rs 95.32 crore, while net profit saw a strong growth of 25.57% to Rs 4.96 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 492% to Rs 7.77 crore, and PBT witnessed a strong rise of 25.37% to Rs 6.82 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 7.11 crore in FY26, as against Rs 5.58 crore in FY25. Medico Intercontinental Ltd nosedived by 22.06% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.05% during the same period.

1 month agoCapital Market - Live
Corporate
Corporate
Medico Intercontinental Limited to review quarterly results at Ahmedabad board meeting August 14

Medico Intercontinental Limited will hold a board meeting on Friday, August 14, 2026, at its registered office in Ahmedabad to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026, and other business items, while the trading window for designated persons and insiders remains closed from June 30, 2026, until 48 hours after the financial results are declared.

1 month agoCapital Market - Live
Earnings
Earnings
Medico Intercontinental reports consolidated net loss of Rs 0.65 crore in the March 2026 quarter

Net loss of Medico Intercontinental reported to Rs 0.65 crore in the quarter ended March 2026 as against net profit of Rs 1.17 crore during the previous quarter ended March 2025. Sales rose 6.29% to Rs 22.49 crore in the quarter ended March 2026 as against Rs 21.16 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 3.20 crore in the year ended March 2026 as against net profit of Rs 5.06 crore during the previous year ended March 2025. Sales declined 11.79% to Rs 84.08 crore in the year ended March 2026 as against Rs 95.32 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales22.4921.16 6 84.0895.32 -12 OPM %7.169.17 -3.548.58 - PBDT-0.131.75 PL -3.917.61 PL PBT-1.551.47 PL -9.346.82 PL NP-0.651.17 PL -3.205.06 PL Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Corporate
Medico Intercontinental to announce Quarterly Result

Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 22 May 2026.

4 months agoCapital Market - Live
Earnings
Earnings
Medico Intercontinental reports consolidated net loss of Rs 0.22 crore in the December 2025 quarter

Net loss of Medico Intercontinental reported to Rs 0.22 crore in the quarter ended December 2025 as against net profit of Rs 1.17 crore during the previous quarter ended December 2024. Sales rose 7.70% to Rs 19.85 crore in the quarter ended December 2025 as against Rs 18.43 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales19.8518.43 8 OPM %8.0110.31 - PBDT0.031.80 -98 PBT-1.401.57 PL NP-0.221.17 PL Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Corporate
Medico Intercontinental to discuss results

Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Earnings
Medico Intercontinental reports consolidated net loss of Rs 1.65 crore in the September 2025 quarter

Net loss of Medico Intercontinental reported to Rs 1.65 crore in the quarter ended September 2025 as against net profit of Rs 1.63 crore during the previous quarter ended September 2024. Sales declined 44.03% to Rs 20.40 crore in the quarter ended September 2025 as against Rs 36.45 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales20.4036.45 -44 OPM %-4.367.43 - PBDT-2.362.53 PL PBT-4.312.33 PL NP-1.651.63 PL Powered by Capital Market - Live

10 months agoCapital Market - Live
Corporate
Corporate
Medico Intercontinental to declare Quarterly Results

Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

10 months agoCapital Market - Live
Corporate
Corporate
Medico Intercontinental schedules AGM

Medico Intercontinental announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live

1 year agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. The share price of MIL as on 18th September 2026 is ₹26.49. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Medico Intercontinental Ltd (MIL) share are
    • Past 1 week: 2.67%
    • Past 1 month: -7.05%
    • Past 3 months: 0.61%
    • Past 6 months: -12.95%
    • Past 1 year: -29.55%
    • Past 3 years: -66.84%
    • Past 5 years: -38.40%

  3. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Medico Intercontinental Ltd (MIL) is ₹26.49 Cr as of 18th September 2026.

  4. The 52-week high of Medico Intercontinental Ltd (MIL) is ₹43 and the 52-week low is ₹20.61.

  5. The P/E (price-to-earnings) ratio of Medico Intercontinental Ltd (MIL) is -8.25. The P/B (price-to-book) ratio is 0.54.

  6. Medico Intercontinental Ltd (MIL) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  7. You can directly buy Medico Intercontinental Ltd (MIL) shares on Tickertape. Simply sign up, connect your demat account and place your order.